Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Funding For US FDA Work On Cannabinoids Regulatory Pathway Drives Progress Only So Far

Apr 08 2021

• By Eileen Francis

Related Content

FDA Action Items For CBD Policy? The List Is Short Due To 'Critical' Data Gaps

Jan 20 2020

$2m For CBD Policy In FDA Budget, But No Directive On Setting Safe Level

Dec 19 2019

US House Appropriators Request CBD Enforcement As They Ante Up $5M For FDA's Rule Development

Jul 10 2020

Legislating US Regulatory Pathway For Cannabinoids ‘Not End of The World’ – Gottlieb

Apr 08 2021

Additional Topics

International United States US States South America Cannabidiol CBD FDA Legislation Commercial Compliance Dietary Supplements Cosmetics Guidance Documents Ingredients Policy Regulation Consumer

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window